Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2003
Published online before print February 13, 2003, doi: 10.1161/01.RES.0000061180.03813.0F
A more recent version of this article appeared on March 21, 2003
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
92/5/501    most recent
01.RES.0000061180.03813.0Fv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fouty, B. W.
Right arrow Articles by Rodman, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fouty, B. W.
Right arrow Articles by Rodman, D. M.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*LOVASTATIN
Medline Plus Health Information
*Statins
Related Collections
Right arrow Pulmonary biology and circulation
Right arrow Smooth muscle proliferation and differentiation

Submitted on September 26, 2002
Revised on January 30, 2003
Accepted on January 31, 2003

Mevastatin Can Cause G1 Arrest and Induce Apoptosis in Pulmonary Artery Smooth Muscle Cells Through a p27Kip1-Independent Pathway

Brian W. Fouty * and David M. Rodman

From the Division of Pulmonary Sciences and Critical Care Medicine (B.W.F., D.M.R.) and Department of Physiology and Biophysics (D.M.R.), University of Colorado Health Sciences Center, Denver, Colo.

* To whom correspondence should be addressed. E-mail: brian.fouty{at}uchsc.edu.

Advanced pulmonary arterial hypertension is characterized by extensive vascular remodeling that is usually resistant to vasodilator therapy. Mevastatin is an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase, the rate-limiting step for cholesterol synthesis. HMG-CoA reductase inhibitors have been shown to upregulate the cyclin-dependent kinase inhibitor p27Kip1 and to block cell proliferation through cholesterol-independent pathways. The aim of this study was to determine the effect of mevastatin on DNA synthesis, cell cycle progression, and cell proliferation in rat pulmonary artery smooth muscle cells (PASMCs). We found that mevastatin induced G1 arrest and decreased DNA synthesis in rat PASMCs and did so in association with an increase in both total and cyclin E-bound p27Kip1. This caused a marked decrease in cyclin E kinase activity, which suggests an important role for p27Kip1 in the ability of mevastatin to induce G1 arrest. However, in PASMCs lacking functional p27Kip1, mevastatin still decreased cyclin E kinase activity, caused G1 arrest, and decreased DNA synthesis. In p27Kip1-deficient PASMCs, mevastatin induced a greater reduction of cyclin E protein levels (to 35% of control) than in wild-type cells (to 70% of control) and also reduced the phosphorylation of cdk2 on threonine 160. Mevastatin also caused apoptosis in both wild-type and p27Kip1-deficient PASMCs and was able to do so at a dose that did not induce cell cycle arrest. These data suggest that HMG-CoA reductase inhibitors can both inhibit cell proliferation and induce apoptosis in PASMCs through p27Kip1-independent pathways and may be important therapeutic agents in pulmonary arterial hypertension.


Key words: vascular smooth muscle • pulmonary hypertension • p27Kip1 • HMG-CoA reductase




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
N. Ferri, A. Granata, C. Pirola, F. Torti, P. J. Pfister, R. Dorent, and A. Corsini
Fluvastatin Synergistically Improves the Antiproliferative Effect of Everolimus on Rat Smooth Muscle Cells by Altering p27Kip1/Cyclin E Expression
Mol. Pharmacol., July 1, 2008; 74(1): 144 - 153.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
C. M. Carlin, A. J. Peacock, and D. J. Welsh
Fluvastatin Inhibits Hypoxic Proliferation and p38 MAPK Activity in Pulmonary Artery Fibroblasts
Am. J. Respir. Cell Mol. Biol., October 1, 2007; 37(4): 447 - 456.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
M. Li, Y. Liu, P. Dutt, B. L. Fanburg, and D. Toksoz
Inhibition of serotonin-induced mitogenesis, migration, and ERK MAPK nuclear translocation in vascular smooth muscle cells by atorvastatin
Am J Physiol Lung Cell Mol Physiol, August 1, 2007; 293(2): L463 - L471.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
E. Gurbanov and X. Shiliang
The key role of apoptosis in the pathogenesis and treatment of pulmonary hypertension.
Eur. J. Cardiothorac. Surg., September 1, 2006; 30(3): 499 - 507.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
P. C. Piotrowski, J. Kwintkiewicz, I. J. Rzepczynska, Y. Seval, H. Cakmak, A. Arici, and A. J. Duleba
Statins Inhibit Growth of Human Endometrial Stromal Cells Independently of Cholesterol Availability
Biol Reprod, July 1, 2006; 75(1): 107 - 111.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
B. Fouty, T. Moss, V. Solodushko, and M. Kraft
Dexamethasone can stimulate G1-S phase transition in human airway fibroblasts in asthma
Eur. Respir. J., June 1, 2006; 27(6): 1160 - 1167.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
D. M. Rodman, K. Reese, J. Harral, B. Fouty, S. Wu, J. West, M. Hoedt-Miller, Y. Tada, K.-X. Li, C. Cool, et al.
Low-Voltage-Activated (T-Type) Calcium Channels Control Proliferation of Human Pulmonary Artery Myocytes
Circ. Res., April 29, 2005; 96(8): 864 - 872.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Ukomadu and A. Dutta
p21-dependent Inhibition of Colon Cancer Cell Growth by Mevastatin Is Independent of Inhibition of G1 Cyclin-dependent Kinases
J. Biol. Chem., October 31, 2003; 278(44): 43586 - 43594.
[Abstract] [Full Text] [PDF]